JIB-04
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- pan-JUMONJI histone demethylase inhibitor
- Produktmerkmale
- A novel specific inhibitor of the Jumonji family of histone demethylases in vitro, in cancer cells and in tumors in vivo. IC50 = 230, 340, 435, 445, 855 and 1100 nM for JARID1A, JMJD2E, JMJD2B, JMJD2A, JMJD3 and JMJD2C respectively. Reduces tumor burden and prolongs life in a mouse model. Suppresses translation initiation and enhances mTOR inhibitor sensitivity. Inhibits the growth of temozolomide-resistant glioblastoma cells and crosses the blood brain barrier.
- Reinheit
- >98 %
- Chemical Name
- (E)-5-Chloro-2-(2-(phenyl(pyridine-2-yl)methylene)hydrazinyl)pyridine
- Formel
- C17H13ClN4
- Permeabilität
- Cell-permeable
- Löslichkeit
- Soluble in DMSO (up to 30 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- -20 °C
-
- Hintergrund
- Epigenetics,Posttranslational modification,Protein demethylase,Cancer,mTOR,Chromatin
- Molekulargewicht
- 308.76
- CAS-Nummer
- 199596-05-9
-